BioSpace News Archive

Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the permanent Manufacturer’s Authorization for its clinical development site in Rankweil, Austria.

November 9, 2023
·
3 min read
Business

MaaT Pharma Provides Third Quarter 2023 Business Update and Reports Financial Results

MaaT Pharma, a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM dedicated to enhancing survival for patients with cancer, provided a business update and reported its cash position as of September 30, 2023.

November 9, 2023
·
8 min read
Biotech Bay

RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

RetinalGeniX™ Technologies Inc., announced that it has submitted two provisional patent applications to the US Patent Office for its investigational therapeutic drug candidates RTG-2023 and RTG-2024.

November 9, 2023
·
5 min read
PharmaDrug Inc. Announces Grant of Stock Options

PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company”), announces that it has granted a total of 6,250,000 stock options (“Options”) to purchase common shares of the Company to certain officers,

November 9, 2023
·
4 min read
Kiora Pharmaceuticals Reports Q3 2023 Results; Expanding Clinical Development of KIO-301 for Inherited Retinal Diseases Based on Encouraging Results of ABACUS-1 Study in Retinitis Pigmentosa

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced its third quarter 2023 financial results and is providing an update on its plans to advance clinical development of KIO-301 for other inherited retinal diseases.

November 9, 2023
·
7 min read
Business

Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer

Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness,

November 9, 2023
·
3 min read
Biotech Beach

Inogen to Present at Upcoming Investor Conferences in November 2023

Inogen, Inc. announced that management will present at the following investor conferences.

November 9, 2023
·
1 min read
Business

PurMinds Appoints Leading Drug Designer, Dr. Alan Kozikowski, to Chief Scientific Officer and Appoints Pharma Veteran Dr. Max Arella to Scientific Advisory Board

PurMinds NeuroPharma (“PurMinds™" or the “Company”), a clinical-stage neuroscience company focused on neurological and neurodegenerative disorders and advancing a robust clinical development

November 9, 2023
·
6 min read
BioMidwest

Molecular Designs releases their new Candida auris PCR Simplicity Panel™

Molecular Designs, a leading provider of molecular infectious disease assays, has released its latest product, the Candida auris Simplicity Panel™.

November 9, 2023
·
2 min read
BioCapital

Visbiome® GI Care High Potency Capsules Now Certified by the Clean Label Project®

ExeGi Pharma LLC, a leader in digestive health solutions, is proud to announce that its flagship product, Visbiome GI Care Probiotic Capsules, has achieved the prestigious Clean Label Project® Certification and Clean Label Project Pesticide Free Certification.

November 9, 2023
·
2 min read